Barbora de Courten
Professor Barbora de Courten is a professor at Monash Centre for Research and Implementation, School of Public Health, Monash University. She a general physician with experience in clinical research, epidemiology and public health in the area of non-communicable disease in particular in obesity, type 2 diabetes and cardiovascular diseases. Her research focuses on chronic low-grade inflammation as a predictor of obesity, type 2 diabetes and cardiovascular diseases and novel preventive interventions that can modulate risk for diabetes and cardiovascular diseases via reduction in chronic inflammation and advanced glycation.
Barbora described 17 predictors and 4 genetic determinants of obesity, insulin resistance and diabetes, elucidated pathways by which chronic low-grade inflammation causes diabetes and their relative contribution in humans. More recently, she investigated anti-inflammatory therapy, diet low in advanced glycation endproducts, vitamin D and carnosine supplementation as strategies to reduce risk for diabetes and cardiovascular disease.
Barbora is involved in national and interventional peer review, is on Editorial boards of 3 journals and NHMRC and DART grant review panels. She is also an active member of Australian National Diabetes Audit (ANDA) Advisory Group and Eli Lilly Innovation Advisory group.
Abstracts this author is presenting: